Interested in promotions? | Click here >>
Chelerythrine Chloride
Activators & Inhibitors
Chemical Modulators

Chelerythrine Chloride #11916

Reviews ()
Citations (0)
other Image 1 - Chelerythrine Chloride

Chemical structure of chelerythrine chloride.

other Image 2 - Chelerythrine Chloride

Western blot analysis of extracts from HeLa cells, serum-starved overnight and untreated or treated with Chelerythrine Chloride (2 hr) at the indicated concentrations, using Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit mAb #4668 (upper) or SAPK/JNK (56G8) Rabbit mAb #9258 (lower).

Product Usage Information

Chelerythrine Chloride is supplied as a lyophilized powder. For a 10 mM stock, reconstitute the 5 mg in 1.30 ml DMSO. Working concentrations and length of treatment can vary depending on the desired effect, but it is typically used at 1-20 µM either as a pretreatment for 15 min-1 hr prior to treating with a stimulator or used alone with varying treatment times lasting up to 24 hr.


Store lyophilized or in solution at -20ºC, desiccated. Protect from light. In lyophilized form, the chemical is stable for 24 months. Once in solution, use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Product Description

Molecular Weight:

383.82 g/mol



Molecular Formula:



Chelerythrine is a benzophenanthridine alkaloid that elicits a wide range of biological responses. It was initially reported to be a potent PKC inhibitor (IC50 = 660 nM) through interaction with the catalytic domain, competitive with respect to the phosphate acceptor, noncompetitive with respect to ATP (1), and is often used in research as a means to inhibit PKC activation (2-4). However, subsequent studies have shown that chelerythrine is not a potent PKC inhibitor and its effects are independent of PKC inhibition (5,6). Researchers have demonstrated that chelerythrine activates JNK and p38 through an oxidative stress mechanism (6), inhibits Bcl-xL by preventing Bcl-xL-Bak BH3 peptide binding (IC50 = 1.5 μM) and disrupting the interaction between Bcl-xL and Bax (7), and induces apoptosis (6-8).

  1. Herbert, J.M. et al. (1990) Biochem Biophys Res Commun 172, 993-9.
  2. Chao, M.D. et al. (1998) Planta Med 64, 662-3.
  3. Nakai, M. et al. (1999) J Neurochem 72, 1179-86.
  4. Iwabu, A. et al. (2004) . J. Biol. Chem. 279 (15), 14551-14560.
  5. Lee, S.K. et al. (1998) J Biol Chem 273, 19829-33.
  6. Yu, R. et al. (2000) J Biol Chem 275, 9612-9.
  7. Chan, S.L. et al. (2003) J Biol Chem 278, 20453-6.
  8. Chmura, S.J. et al. (2000) Clin Cancer Res 6, 737-42.
For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

To Purchase # 11916S
Product # Size Price
5 mg $ 141

Our US Office is Closed

Our US office is closed in observance of Independence Day. We will reopen on Monday, July 6th.

Thank you for your patience.